<DOC>
	<DOCNO>NCT02317263</DOCNO>
	<brief_summary>This multicenter , prospective , placebo-controlled , double-blind randomized Phase II clinical trial assess effect testosterone treatment vs. placebo treatment 96 week duration whole brain atrophy men MS .</brief_summary>
	<brief_title>A Trial Investigate Effectiveness Testosterone Treatment Men With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men , age 1860 , diagnosis multiple sclerosis 2010 revise McDonald Criteria</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>MS</keyword>
</DOC>